Table 1. Plasma fibrinogen level and clinicopathological characteristics in 255 ESCC patients.
| Variables | Patients (n) | Plasma fibrinogen level | P | |
|---|---|---|---|---|
| Normal (<4 g/L) | High (>4 g/L) | |||
| Gender | ||||
| Female | 23 | 19 (82.6) | 4 (17.4) | 0.018 |
| Male | 232 | 133 (57.3) | 99 (42.7) | |
| Age (years) | ||||
| ≥65 Y | 31 | 23 (74.2) | 8 (25.8) | 0.077 |
| <65 Y | 224 | 129 (57.6) | 95 (42.4) | |
| Smoking | ||||
| Never | 41 | 29 (70.7) | 12 (29.3) | 0.113 |
| Ever | 214 | 123 (57.5) | 91 (42.5) | |
| Alcohol | ||||
| Never | 72 | 49 (68.1) | 23 (31.9) | 0.085 |
| Ever | 183 | 103 (56.3) | 80 (43.7) | |
| Differentiation | ||||
| Well | 30 | 20 (66.7) | 10 (33.3) | 0.664 |
| Moderately | 179 | 104 (58.1) | 75 (41.9) | |
| Poorly | 46 | 28 (60.9) | 18 (39.1) | |
| Tumor location | ||||
| Upper | 6 | 3 (50.0) | 3 (50.0) | 0.012 |
| Middle | 123 | 85 (69.1) | 38 (30.9) | |
| Lower | 126 | 64 (50.8) | 62 (49.2) | |
| Tumor length | ||||
| ≤5 cm | 197 | 135 (68.5) | 62 (31.5) | <0.001 |
| >5 cm | 58 | 17 (29.3) | 41 (70.7) | |
| T stage | ||||
| T1 | 36 | 32 (88.9) | 4 (11.1) | <0.001 |
| T2 | 49 | 39 (79.6) | 10 (20.4) | |
| T3 | 151 | 75 (49.7) | 76 (50.3) | |
| T4 | 19 | 6 (31.6) | 13 (68.4) | |
| N stage | ||||
| N0 | 127 | 89 (70.1) | 38 (29.9) | 0.004 |
| N1 | 74 | 40 (54.1) | 34 (45.9) | |
| N2 | 38 | 17 (44.7) | 21 (55.3) | |
| N3 | 16 | 6 (37.5) | 10 (62.5) | |
| Locoregional relapse | ||||
| Yes | 32 | 21 (65.6) | 11 (34.4) | 0.458 |
| No | 223 | 131(58.7) | 92(41.3) | |
| Distant metastasis | ||||
| Yes | 92 | 37(40.2) | 55(59.8) | <0.001 |
| No | 163 | 115(70.6) | 48(29.4) | |
| Any relapse | ||||
| Yes | 121 | 55(45.5) | 66(54.5) | <0.001 |
| No | 134 | 97(72.4) | 37(27.6) | |
| Deaths | ||||
| Yes | 81 | 34(42.0) | 47(58.0) | <0.001 |
| No | 174 | 118(67.8) | 56(32.2) | |
Bold values are statistically significant (P < 0.05).